Myanmar vs Pakistan: Cause of death, by non-communicable diseases, ages 15-59
Myanmar
56.4%
in 2021
Pakistan
56.6%
in 2021
Myanmar rank
85th
Pakistan rank
84th
Cause of death, by non-communicable diseases, ages 15-59 over time
- Myanmar
- Pakistan
How they compare
Pakistan currently reports 56.6% against 56.4% in Myanmar, a difference of 0.2%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Pakistan ahead.
Myanmar ranks 85th and Pakistan ranks 84th of 185 countries.
Across the 3 decades both report, Myanmar averaged higher in 1 and Pakistan in 2.
Head to head by decade
| Decade | Myanmar | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 51.2% | 58.0% | 6.9% | Pakistan |
| 2010s | 60.7% | 62.4% | 1.7% | Pakistan |
| 2020s | 61.1% | 57.1% | 3.9% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, Myanmar or Pakistan?
- Pakistan, at 56.6% against 56.4% in Myanmar as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between Myanmar and Pakistan?
- 0.2%, with Pakistan ahead.
- How many years of comparable data are there for Myanmar and Pakistan?
- 6 years are reported by both, from 2000 to 2021.
- How do Myanmar and Pakistan rank globally for cause of death, by non-communicable diseases, ages 15-59?
- Myanmar ranks 85th and Pakistan ranks 84th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.